The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Increase in tumor burden at disease progression as a predictor of survival in advanced NSCLC patients.
 
Yuri Kogan
Employment - Optimata
Stock and Other Ownership Interests - Optimata
Travel, Accommodations, Expenses - Optimata
 
Moran Elishmereni
Employment - Optimata
Stock and Other Ownership Interests - Optimata
 
Eldad Taub
Employment - Optimata
Leadership - Optimata
Stock and Other Ownership Interests - Optimata
Travel, Accommodations, Expenses - Optimata
 
Zvia Agur
Employment - Optimata
Leadership - Optimata
Stock and Other Ownership Interests - Optimata